It's gone downhill from there.
I'm trying to get organized for my move to
Expensive disease, this. And it's only beginning. The pharmacist figures out I spent $16,000 on meds last year - most of it covered by insurance, thank gods, but this year my coverage stops at $2400 (the max available under my insurance). Even the support program only pays for 80%. As my income is about twice my drug total, life is looking a bit grim. Perhaps I will have to just give them up. Or maybe the makers of Copaxone, Teva pharmaceuticals, who were in fact fined for overcharging, could lower their prices a wee bit. I know, overall, it is less costly than the alternative - crippling disease progression - and it seems to have stopped that for me. I know it's expensive to make, and involves years of research - I know they have to charge a hefty fee. But perhaps a wee bit less hefty would be a big help.
1 comment:
DA, perhaps this small study available on PubMed that looked at the efficacy of alternate day dosing with Copaxone might be of interest to you:
http://www.ncbi.nlm.nih.gov/pubmed/11852290
Unfortunately, (given it was done in 2002) there doesn't seem to have been any further followup to its recommendations ...
Wow - good luck with the move.
Post a Comment